Inconsistencies in Quality of Life Data Collection in Clinical Trials: A Potential Source of Bias? Interviews with Research Nurses and Trialists

被引:47
作者
Kyte, Derek [1 ]
Ives, Jonathan [1 ]
Draper, Heather [1 ]
Keeley, Thomas [1 ,2 ]
Calvert, Melanie [1 ,2 ]
机构
[1] Univ Birmingham, Birmingham, W Midlands, England
[2] Univ Birmingham, MRC Midland Hub Trials Methodol Res, Birmingham, W Midlands, England
基金
英国医学研究理事会;
关键词
PATIENT-REPORTED OUTCOMES; PRESCRIBING RESEARCH; ETHICAL-ISSUES; RECOMMENDATIONS; GUIDANCE; PROTOCOL;
D O I
10.1371/journal.pone.0076625
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Patient-reported outcomes (PROs), such as health-related quality of life (HRQL) are increasingly used to evaluate treatment effectiveness in clinical trials, are valued by patients, and may inform important decisions in the clinical setting. It is of concern, therefore, that preliminary evidence, gained from group discussions at UK-wide Medical Research Council (MRC) quality of life training days, suggests there are inconsistent standards of HRQL data collection in trials and appropriate training and education is often lacking. Our objective was to investigate these reports, to determine if they represented isolated experiences, or were indicative of a potentially wider problem. Methods And Findings: We undertook a qualitative study, conducting 26 semi-structured interviews with research nurses, data managers, trial coordinators and research facilitators involved in the collection and entry of HRQL data in clinical trials, across one primary care NHS trust, two secondary care NHS trusts and two clinical trials units in the UK. We used conventional content analysis to analyze and interpret our data. Our study participants reported (1) inconsistent standards in HRQL measurement, both between, and within, trials, which appeared to risk the introduction of bias; (2), difficulties in dealing with HRQL data that raised concern for the well-being of the trial participant, which in some instances led to the delivery of non-protocol driven co-interventions, (3), a frequent lack of HRQL protocol content and appropriate training and education of trial staff, and (4) that HRQL data collection could be associated with emotional and/or ethical burden. Conclusions: Our findings suggest there are inconsistencies in the standards of HRQL data collection in some trials resulting from a general lack of HRQL-specific protocol content, training and education. These inconsistencies could lead to biased HRQL trial results. Future research should aim to develop HRQL guidelines and training programmes aimed at supporting researchers to carry out high quality data collection.
引用
收藏
页数:11
相关论文
共 43 条
[1]  
[Anonymous], 2009, GUID IND PAT REP OUT
[2]  
[Anonymous], INTERVIEWING SAGE BE
[3]  
[Anonymous], 2008, CLIN RES REGUL AFF, DOI DOI 10.1080/10601330802471162
[4]  
[Anonymous], 2005, Official Journal of European Union
[5]  
[Anonymous], 2002, Guidance on the use of trastuzumab for the treatment of advanced breast cancer
[6]  
[Anonymous], GOOD CLIN PRACTICE J
[7]  
[Anonymous], 2008, The Code: Standards of conduct, performance and ethics for Nurses and Midwives
[8]  
[Anonymous], 2010, DOING QUALITATIVE RE
[9]   Recommendations for assessing Patient-Reported Outcomes and Health-Related quality of life in clinical trials on allergy: a GA2LEN taskforce position paper [J].
Baiardini, I. ;
Bousquet, P. J. ;
Brzoza, Z. ;
Canonica, G. W. ;
Compalati, E. ;
Fiocchi, A. ;
Fokkens, W. ;
van Wijk, R. G. ;
La Grutta, S. ;
Lombardi, C. ;
Maurer, M. ;
Pinto, A. M. ;
Ridolo, E. ;
Senna, G. E. ;
Terreehorst, I. ;
Bom, A. Todo ;
Bousquet, J. ;
Zuberbier, T. ;
Braido, F. .
ALLERGY, 2010, 65 (03) :290-295
[10]   DEVELOPMENT OF A GUIDANCE FOR INCLUDING PATIENT-REPORTED OUTCOMES (PROS) IN POST-APPROVAL CLINICAL TRIALS OF ONCOLOGY DRUGS FOR COMPARATIVE EFFECTIVENESS RESEARCH (CER) [J].
Basch, E. M. ;
Abernethy, A. ;
Mullins, C. D. ;
Tiglao, M. R. ;
Tunis, S. R. .
VALUE IN HEALTH, 2011, 14 (03) :A10-A10